Yusuf Menda
Yusuf Menda
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent | Neuroendocrine Tumor Grade 1; Neuroendocrine Tumor Grade 2 | Active, not recruiting | Early phase 1 | 2025-07-14 | NCT05111509 | |
| Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Early phase 1 | 2025-07-14 | NCT03335670 | |
| A Safety Study of 212Pb-Pentixather Radioligand Therapy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Not yet recruiting | Early phase 1 | 2025-07-08 | NCT05557708 |